FLGTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Fulgent Genetics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$20.10+0.29 (+1.46%)
Close on Oct 19, 2026
- Market cap
- $562.90M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
57.0%
16M of 28M shares
Institutional holders
142
21 new, 36 sold out
Net institutional buying
-2M
In Q2 2026
Insider trades, 12 months
0 buys · 15 sales
Net sold $677.63K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Ming Hsieh | 8,872,539 | 32.26% | 13D (active) amendment | May 22, 2026 |
| Barclays PLC | 2,338,451 | 7.57% | 13G (passive) amendment | Mar 31, 2025 |
| BlackRock, Inc. | 1,819,823 | 5.90% | 13G (passive) amendment | Mar 31, 2025 |
| Millennium Management LLC | 1,691,811 | 5.60% | 13G (passive) amendment | Jul 22, 2025 |
| Ramya Rao | 1,658,059 | 5.42% | 13G (passive) | Dec 31, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of FLGT | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2,286,669 | 8.31% | $46.92M | −487,850 | 0.00% |
| Acadian Asset Management LLC | 1,017,913 | 3.70% | $20.87K | −216,038 | 0.02% |
| Vanguard Capital Management LLC | 789,498 | 2.87% | $16.20M | −90,652 | 0.00% |
| Jacobs Levy Equity Management, Inc | 782,116 | 2.84% | $16.05M | +425,757 | 0.06% |
| JPMorgan Chase & Co | 756,558 | 2.75% | $15.53M | +296,195 | 0.00% |
| Diametric Capital, LP | 697,784 | 2.54% | $14.32M | +336,738 | 1.51% |
| Ameriprise Financial Inc | 670,084 | 2.44% | $13.75M | +106,709 | 0.00% |
| Dimensional Fund Advisors LP | 625,355 | 2.27% | $12.83M | −46,309 | 0.00% |
| Geode Capital Management, LLC | 521,014 | 1.89% | $10.69M | −63,193 | 0.00% |
| State Street Corp | 498,673 | 1.81% | $10.23M | −30,726 | 0.00% |
| Invenomic Capital Management LP | 498,287 | 1.81% | $10.22M | −112,031 | 0.61% |
| Two Sigma Investments, LP | 400,986 | 1.46% | $8.23M | +78,797 | 0.01% |
| Charles Schwab Investment Management Inc | 350,987 | 1.28% | $7.20M | −3,197 | 0.00% |
| Millennium Management LLC | 320,910 | 1.17% | $6.59M | −80,909 | 0.00% |
| Goldman Sachs Group Inc | 307,940 | 1.12% | $6.32M | −3,483 | 0.00% |
| D. E. Shaw & Co., Inc. | 292,006 | 1.06% | $5.99M | −194,764 | 0.00% |
| Hrt Financial LP | 229,444 | 0.83% | $4.71K | +182,996 | 0.00% |
| Peapod Lane Capital LLC | 224,207 | 0.81% | $4.60M | +3,580 | 3.10% |
| Point72 Asset Management, L.P. | 211,708 | 0.77% | $4.34M | New | 0.00% |
| Medina Value Partners, LLC | 193,061 | 0.70% | $3.96M | +22,992 | 0.78% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 142 | 16M | 57.0% | 21 / 40 | 55 / 36 | 3M | 4M |
| Q1 2026 | 158 | 17M | 63.5% | 29 / 48 | 56 / 46 | 5M | 4M |
| Q4 2025 | 179 | 18M | 65.1% | 34 / 55 | 54 / 14 | 3M | 2M |
| Q3 2025 | 163 | 18M | 63.8% | 19 / 56 | 52 / 22 | 3M | 1M |
| Q2 2025 | 167 | 16M | 59.1% | 20 / 59 | 51 / 27 | 3M | 3M |
| Q1 2025 | 176 | 16M | 59.3% | 26 / 63 | 50 / 36 | 4M | 4M |
| Q4 2024 | 189 | 17M | 61.8% | 31 / 70 | 50 / 25 | 2M | 1M |
| Q3 2024 | 183 | 16M | 59.7% | 33 / 48 | 58 / 22 | 6M | 1M |
| Q2 2024 | 174 | 15M | 56.1% | 30 / 58 | 49 / 34 | 1M | 2M |
| Q1 2024 | 180 | 16M | 56.4% | 25 / 52 | 61 / 39 | 2M | 2M |
| Q4 2023 | 196 | 15M | 54.2% | 28 / 51 | 74 / 31 | 2M | 2M |
| Q3 2023 | 201 | 14M | 51.7% | 21 / 62 | 68 / 31 | 2M | 1M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of FLGT | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 551,839 | 2.01% | $11.32M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 514,046 | 1.87% | $10.55M | 0.01% | Jun 30, 2026 |
| Columbia Small Cap Value Discovery Fund | 396,579 | 1.44% | $6.56M | 0.26% | Jul 31, 2026 |
| BlackRock Advantage Small Cap Core Fund | 306,170 | 1.11% | $5.55M | 0.11% | May 29, 2026 |
| Invenomic Fund | 262,951 | 0.96% | $4.35M | 0.51% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 217,572 | 0.79% | $4.46M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 212,867 | 0.77% | $3.52M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Value ETF | 178,697 | 0.65% | $3.67M | 0.03% | Jun 30, 2026 |
| Schwab Fundamental U.S. Small Company ETF | 135,029 | 0.49% | $2.45M | 0.03% | May 31, 2026 |
| iShares Biotechnology ETF | 128,918 | 0.47% | $2.65M | 0.03% | Jun 30, 2026 |
| U.S. Small Cap Portfolio | 122,950 | 0.45% | $2.03M | 0.01% | Jul 31, 2026 |
| Fidelity Extended Market Index Fund | 110,018 | 0.40% | $2.00M | 0.00% | May 31, 2026 |
| Vanguard Russell 2000 Index Fund | 107,764 | 0.39% | $1.95M | 0.01% | May 31, 2026 |
| U.S. Micro Cap Portfolio | 102,809 | 0.37% | $1.70M | 0.02% | Jul 31, 2026 |
| Multi-Manager Small Cap Equity Strategies Fund | 101,496 | 0.37% | $1.84M | 0.14% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Ming Hsieh | Chief Executive Officer, Director, 10% owner | 8,783,067 | 31.92% | Sep 3, 2026 |
| Paul Kim | CFO and Treasurer | 356,543 | 1.30% | Sep 3, 2026 |
| Jian Xie | President and COO | 580,740 | 2.11% | Sep 3, 2026 |
| Hanlin Gao | Chief Scientific Officer | 986,117 | 3.58% | Sep 3, 2026 |
| Michael Nohaile | Director | 24,578 | 0.09% | May 18, 2026 |
| Regina E. Groves | Director | 28,099 | 0.10% | May 18, 2026 |
| Linda Dong | Director | 38,758 | 0.14% | May 18, 2026 |
| Hsieh Trust Ming | 10% owner | 8,760,703 | 31.84% | Mar 31, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Hanlin Gao Chief Scientific Officer | Sep 2, 2026 | Sale | −1,673 | $19.66 | $32.89K | 986,117 |
| Jian Xie President and COO | Sep 2, 2026 | Sale | −2,127 | $19.66 | $41.82K | 359,924 |
| Ming Hsieh Chief Executive Officer, Director, 10% owner | Sep 1, 2026 | Tax withholding | −4,392 | $19.59 | $86.04K | 885,952 |
| Paul Kim CFO and Treasurer | Sep 1, 2026 | Tax withholding | −2,087 | $19.59 | $40.88K | 356,543 |
| Jian Xie President and COO | Aug 27, 2026 | Sale | −1,193 | $19.91 | $23.75K | 362,051 |
| Hanlin Gao Chief Scientific Officer | Aug 27, 2026 | Sale | −939 | $19.91 | $18.70K | 987,790 |
| Paul Kim CFO and Treasurer | Aug 26, 2026 | Tax withholding | −1,168 | $19.81 | $23.14K | 358,630 |
| Ming Hsieh Chief Executive Officer, Director, 10% owner | Aug 26, 2026 | Tax withholding | −2,949 | $19.81 | $58.42K | 890,344 |
| Jian Xie President and COO | Jul 26, 2026 | Tax withholding | −4,361 | $19.67 | $85.78K | 363,244 |
| Paul Kim CFO and Treasurer | Jul 26, 2026 | Tax withholding | −2,747 | $19.67 | $54.03K | 359,798 |
| Hanlin Gao Chief Scientific Officer | Jul 26, 2026 | Tax withholding | −1,645 | $19.67 | $32.36K | 988,729 |
| Hanlin Gao Chief Scientific Officer | Jun 2, 2026 | Sale | −1,688 | $17.89 | $30.20K | 990,374 |
| Jian Xie President and COO | Jun 2, 2026 | Sale | −2,146 | $17.89 | $38.39K | 367,605 |
| Paul Kim CFO and Treasurer | Jun 1, 2026 | Tax withholding | −2,087 | $18.09 | $37.75K | 362,545 |
| Ming Hsieh Chief Executive Officer, Director, 10% owner | Jun 1, 2026 | Tax withholding | −4,392 | $18.09 | $79.45K | 893,293 |
| Hanlin Gao Chief Scientific Officer | May 27, 2026 | Sale | −945 | $17.60 | $16.63K | 992,062 |
| Jian Xie President and COO | May 27, 2026 | Sale | −1,201 | $17.60 | $21.14K | 369,751 |
| Paul Kim CFO and Treasurer | May 26, 2026 | Tax withholding | −1,168 | $17.67 | $20.64K | 364,632 |
| Ming Hsieh Chief Executive Officer, Director, 10% owner | May 26, 2026 | Tax withholding | −2,949 | $17.67 | $52.11K | 897,685 |
| Linda Dong Director | May 14, 2026 | Award | +11,117 | – | – | 38,758 |
| Regina E. Groves Director | May 14, 2026 | Award | +11,117 | – | – | 28,099 |
| Michael Nohaile Director | May 14, 2026 | Award | +5,558 | – | – | 24,578 |
| Jian Xie President and COO | Apr 26, 2026 | Tax withholding | −4,361 | $16.31 | $71.13K | 370,952 |
| Hanlin Gao Chief Scientific Officer | Apr 26, 2026 | Tax withholding | −1,645 | $16.31 | $26.83K | 993,007 |
| Paul Kim CFO and Treasurer | Apr 26, 2026 | Tax withholding | −2,747 | $16.31 | $44.80K | 365,800 |
| Ming Hsieh Chief Executive Officer, Director, 10% owner | Mar 1, 2026 | Tax withholding | −17,566 | $15.33 | $269.29K | 900,634 |
| Hanlin Gao Chief Scientific Officer | Mar 1, 2026 | Tax withholding | −6,410 | $15.33 | $98.27K | 994,652 |
| Hanlin Gao Chief Scientific Officer | Mar 1, 2026 | Tax withholding | −1,018 | $15.33 | $15.61K | 1,001,062 |
| Jian Xie President and COO | Mar 1, 2026 | Tax withholding | −1,079 | $15.33 | $16.54K | 383,460 |
| Jian Xie President and COO | Mar 1, 2026 | Tax withholding | −8,147 | $15.33 | $124.89K | 375,313 |
| Paul Kim CFO and Treasurer | Mar 1, 2026 | Tax withholding | −8,347 | $15.33 | $127.96K | 368,547 |
| Paul Kim CFO and Treasurer | Mar 1, 2026 | Tax withholding | −1,133 | $15.33 | $17.37K | 376,894 |
| Ming Hsieh Chief Executive Officer, Director, 10% owner | Feb 26, 2026 | Tax withholding | −2,949 | $24.76 | $73.02K | 918,200 |
| Hanlin Gao Chief Scientific Officer | Feb 26, 2026 | Tax withholding | −897 | $24.76 | $22.21K | 1,002,080 |
| Jian Xie President and COO | Feb 26, 2026 | Tax withholding | −1,140 | $24.76 | $28.23K | 384,539 |
| Paul Kim CFO and Treasurer | Feb 26, 2026 | Tax withholding | −1,168 | $24.76 | $28.92K | 378,027 |
| Jian Xie President and COO | Feb 24, 2026 | Award | +5,862 | – | – | 337,245 |
| Jian Xie President and COO | Feb 24, 2026 | Award | +15,299 | – | – | 352,544 |
| Jian Xie President and COO | Feb 24, 2026 | Award | +27,341 | – | – | 379,885 |
| Jian Xie President and COO | Feb 24, 2026 | Tax withholding | −3,163 | $23.09 | $73.03K | 376,722 |
| Jian Xie President and COO | Feb 24, 2026 | Tax withholding | −8,254 | $23.09 | $190.58K | 368,468 |
| Jian Xie President and COO | Feb 24, 2026 | Tax withholding | −14,751 | $23.09 | $340.60K | 353,717 |
| Jian Xie President and COO | Feb 24, 2026 | Award | +31,962 | – | – | 385,679 |
| Hanlin Gao Chief Scientific Officer | Feb 24, 2026 | Tax withholding | −2,489 | $23.09 | $57.47K | 989,126 |
| Hanlin Gao Chief Scientific Officer | Feb 24, 2026 | Award | +22,806 | – | – | 991,615 |
| Hanlin Gao Chief Scientific Officer | Feb 24, 2026 | Award | +12,762 | – | – | 968,809 |
| Hanlin Gao Chief Scientific Officer | Feb 24, 2026 | Award | +4,891 | – | – | 956,047 |
| Hanlin Gao Chief Scientific Officer | Feb 24, 2026 | Award | +26,661 | – | – | 1,002,977 |
| Hanlin Gao Chief Scientific Officer | Feb 24, 2026 | Tax withholding | −8,149 | $23.09 | $188.16K | 976,316 |
| Hanlin Gao Chief Scientific Officer | Feb 24, 2026 | Tax withholding | −4,661 | $23.09 | $107.62K | 984,465 |
| Ming Hsieh Chief Executive Officer, Director, 10% owner | Feb 24, 2026 | Award | +69,294 | – | – | 921,149 |
| Ming Hsieh Chief Executive Officer, Director, 10% owner | Feb 24, 2026 | Tax withholding | −31,760 | $23.09 | $733.34K | 851,855 |
| Ming Hsieh Chief Executive Officer, Director, 10% owner | Feb 24, 2026 | Tax withholding | −21,354 | $23.09 | $493.06K | 883,615 |
| Ming Hsieh Chief Executive Officer, Director, 10% owner | Feb 24, 2026 | Tax withholding | −10,230 | $23.09 | $236.21K | 904,969 |
| Ming Hsieh Chief Executive Officer, Director, 10% owner | Feb 24, 2026 | Award | +59,276 | – | – | 915,199 |
| Ming Hsieh Chief Executive Officer, Director, 10% owner | Feb 24, 2026 | Award | +39,802 | – | – | 855,923 |
| Ming Hsieh Chief Executive Officer, Director, 10% owner | Feb 24, 2026 | Award | +19,067 | – | – | 816,121 |
| Paul Kim CFO and Treasurer | Feb 24, 2026 | Award | +5,721 | – | – | 333,206 |
| Paul Kim CFO and Treasurer | Feb 24, 2026 | Award | +14,926 | – | – | 348,132 |
| Paul Kim CFO and Treasurer | Feb 24, 2026 | Award | +26,673 | – | – | 374,805 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Hanlin Gao Officer | Sep 2, 2026 | 1,673 | $32.89K | Sep 2, 2026 | Restricted stock vest |
| Jian Xie Officer | Sep 2, 2026 | 2,127 | $41.81K | Sep 2, 2026 | Resticted stock vest |
| Jian Xie Officer | Aug 27, 2026 | 1,193 | $23.75K | Aug 27, 2026 | Resticted stock vest |
| Hanlin Gao Officer | Aug 27, 2026 | 939 | $18.69K | Aug 27, 2026 | Restricted stock vest |
| Jian Xie Officer | Jun 2, 2026 | 2,146 | $38.38K | Jun 2, 2026 | Resticted stock vest |
| Hanlin Gao Officer | Dec 1, 2025 | 1,070 | $30.52K | Dec 2, 2025 | Restricted stock vest |
| Jian Xie Officer | Dec 1, 2025 | 1,135 | $32.37K | Dec 2, 2025 | Resticted stock vest |
| Jian Xie Officer | Nov 26, 2025 | 1,198 | $36.12K | Nov 28, 2025 | Resticted stock vest |
| Hanlin Gao Officer | Nov 26, 2025 | 943 | $28.43K | Nov 28, 2025 | Restricted stock vest |
| Hanlin Gao Officer | Nov 24, 2025 | 535 | $16.30K | Nov 24, 2025 | Restricted stock vest |
| Jian Xie Officer | Nov 24, 2025 | 681 | $20.75K | Nov 24, 2025 | Resticted stock vest |
| Jian Xie Officer | Nov 19, 2025 | 20,000 | $580.98K | Nov 19, 2025 | Resticted stock vest |
| Jian Xie Officer | Sep 3, 2025 | 1,128 | $24.85K | Sep 3, 2025 | Resticted stock vest |
| Hanlin Gao Officer | Sep 3, 2025 | 1,063 | $23.41K | Sep 3, 2025 | Restricted stock vest |
| Hanlin Gao Officer | Aug 27, 2025 | 943 | $20.26K | Aug 27, 2025 | Restricted stock vest |